Jeff Yass’s Apollomics APLM Stock Holding History

Jeff Yass’s Portfolio APLM Stock Details APLM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-139	Closed	-$52.2K	–	12295
2023 Q3	$52.2K	Buy	+139	New	+$67.9K	﹤0.01%	11286

Other funds holding APLM

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bensler Bellevue, Washington $1.13B AUM 38.91% 1-Year Est. Return

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

ZIG

Zullo Investment Group Scranton, Pennsylvania $293M AUM 36.63% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Jeff Yass's APLM Position: Q4 2023 in Review

Jeff Yass sold out of Apollomics (APLM) in Q4 2023, closing a stake of 139 shares — an estimated $52.2K sold.

Jeff Yass first reported a position in APLM in Q3 2023 and held it in 1 quarter. The position peaked at $52.2K in Q3 2023. 12 funds tracked by Wall St. Rank hold APLM as of Q4 2023.

Jeff Yass reported no remaining Apollomics position as of Q4 2023 after selling out during the quarter.
Jeff Yass sold 139 Apollomics shares in Q4 2023, an estimated $52.2K.
Jeff Yass first reported a position in Apollomics in Q3 2023 and held it in 1 quarter.
Jeff Yass's Apollomics position peaked at $52.2K in Q3 2023.
12 funds tracked by Wall St. Rank held Apollomics as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.